H Takano Selected Research

H Takano Research Topics

Disease

13	Inflammation (Inflammations) 07/2010 - 07/2001
7	Neoplasms (Cancer) 11/2004 - 01/2000
5	Pneumonia (Pneumonitis) 04/2009 - 01/2007
4	Lung Injury 07/2008 - 07/2003
4	Necrosis 08/2005 - 03/2000
4	Infarction (Infarctions) 08/2001 - 11/2000
3	Asthma (Bronchial Asthma) 09/2016 - 11/2001
3	Arthritis (Polyarthritis) 11/2007 - 01/2005
3	Rheumatoid Arthritis 08/2005 - 07/2000
3	Ischemia 08/2001 - 11/2000
3	Coronary Occlusion 11/2000 - 08/2000
2	Hemorrhage 07/2014 - 03/2000
2	Pain (Aches) 02/2014 - 09/2000
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 11/2012 - 04/2000
2	Hyperplasia 07/2010 - 07/2000
2	Anaphylaxis (Anaphylactic Shock) 01/2007 - 09/2001
2	Carcinogenesis 08/2006 - 11/2004
2	Acute Lung Injury 12/2004 - 07/2003
2	Heart Failure 08/2003 - 09/2000
2	Hypotension (Low Blood Pressure) 11/2001 - 09/2001
2	Myocardial Infarction 08/2001 - 08/2000
2	Carcinoma (Carcinomatosis) 07/2001 - 07/2001
2	Myocardial Stunning (Stunned Myocardium) 11/2000 - 08/2000
2	Stroke (Strokes) 09/2000 - 04/2000
1	Blister (Bulla) 10/2021
1	Dermatitis 10/2021
1	Vascular Remodeling 01/2017
1	Wounds and Injuries (Trauma) 01/2017
1	Bone Resorption 05/2016
1	Sneezing 01/2016
1	Allergic Rhinitis 01/2016
1	Hypesthesia (Numbness) 09/2015
1	Lingual Nerve Injuries 09/2015
1	Clinical Deterioration 07/2014
1	Pulmonary Embolism 07/2014
1	Malocclusion (Crossbite) 02/2014
1	Xerostomia 06/2012
1	Atopic Dermatitis (Atopic Eczema) 01/2010
1	Prostatic Neoplasms (Prostate Cancer) 02/2009

Drug/Important Bio-Agent (IBA)

9	Vehicle Emissions (Emissions, Vehicle)IBA 09/2016 - 07/2003
9	CytokinesIBA 04/2009 - 07/2000
7	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2016 - 07/2003
7	AntigensIBA 01/2008 - 01/2005
5	OvalbuminIBA 10/2008 - 11/2001
5	Proteins (Proteins, Gene)FDA Link 01/2008 - 08/2000
4	AllergensIBA 07/2010 - 06/2004
4	InterleukinsIBA 04/2009 - 07/2007
4	Chemotactic FactorsIBA 04/2009 - 01/2007
4	Messenger RNA (mRNA)IBA 02/2009 - 08/2000
4	LipopolysaccharidesIBA 07/2008 - 07/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2007 - 07/2000
3	ChemokinesIBA 04/2009 - 06/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2008 - 12/2001
3	Immunoglobulins (Immunoglobulin)IBA 01/2008 - 09/2005
3	Organic Chemicals (Chemicals, Organic)IBA 02/2007 - 07/2003
2	NaphthoquinonesIBA 09/2016 - 02/2007
2	AntioxidantsIBA 01/2016 - 11/2000
2	Heparin (Liquaemin)FDA LinkGeneric 07/2014 - 09/2001
2	Pharmaceutical PreparationsIBA 06/2012 - 02/2000
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 04/2009 - 07/2007
2	NF-kappa B (NF-kB)IBA 04/2009 - 09/2000
2	Interleukin-6 (Interleukin 6)IBA 07/2008 - 07/2007
2	8-Hydroxy-2'-DeoxyguanosineIBA 08/2006 - 11/2004
2	Interleukin-5 (Interleukin 5)IBA 03/2006 - 06/2004
2	Immunoglobulin G (IgG)IBA 03/2006 - 01/2005
2	Dextran SulfateIBA 08/2005 - 09/2001
2	Interleukin-1beta (Interleukin 1 beta)IBA 08/2005 - 03/2001
2	EndotoxinsIBA 12/2004 - 07/2003
2	ProstaglandinsIBA 11/2001 - 08/2000
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2001 - 04/2000
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2001 - 02/2001
2	oxidized low density lipoproteinIBA 09/2001 - 02/2001
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 08/2001 - 08/2000
2	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 08/2001 - 03/2001
2	Etoposide (VP 16)FDA LinkGeneric 07/2001 - 07/2001
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2001 - 11/2000
2	5-hydroxydecanoic acidIBA 03/2001 - 11/2000
2	Adenosine Triphosphate (ATP)IBA 03/2001 - 11/2000
2	Nitroarginine (NG Nitro L Arginine)IBA 03/2001 - 11/2000
2	EnzymesIBA 08/2000 - 02/2000
1	Cantharidin (Cantharides)IBA 10/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Tartrate-Resistant Acid PhosphataseIBA 05/2016
1	ragweed pollenIBA 01/2016
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2016
1	Dental Implants (Dental Implant)IBA 09/2015
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2015
1	Valsartan (Vals)FDA Link 11/2012
1	A-Form DNA (A-DNA)IBA 06/2012
1	CC ChemokinesIBA 01/2010
1	Eicosapentaenoic AcidIBA 02/2009
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2009
1	Voltage-Gated Sodium ChannelsIBA 02/2009
1	SandIBA 10/2008

Therapy/Procedure

2	Therapeutics 07/2014 - 05/2000
2	Oral Administration 08/2005 - 06/2004
2	Blood Component Removal (Apheresis) 09/2001 - 02/2001
1	Thrombolytic Therapy 07/2014
1	Aftercare (After-Treatment) 02/2014